Severe Acute Hepatitis B Treated With Entecavir

被引：11
|
作者：
De Socio, Giuseppe Vittorio Luigi [1 ]
Sgrelli, Alessio [1 ]
Tosti, Andrea [1 ]
Baldelli, Franco [1 ]
机构：
[1] Univ Perugia, Santa Maria Misericordia Hosp, Dept Infect Dis, Perugia, Italy
来源：
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES | 2011年 / 3卷 / 01期
关键词：
D O I：
10.4084/MJHID.2011.010
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Hepatitis B virus (HBV) infection constitutes a serious global health problem. Nowadays there are divergent data regarding the use of antiviral drugs to treat acute hepatitis B. We present here a case of a 62-year-old man affected by severe acute hepatitis B with progressive worsening of clinical and hepatic function. The patient was treated with entecavir without critical side effects. We observed rapid clinical and laboratory improvements and the disappearance of hepatitis B surface antigen (HBsAg). The treatment with entecavir was protracted until 17th week when the antibody anti-HBs appeared. Entecavir should be carefully considered for the treatment of severe acute hepatitis B cases.
引用
收藏
页数：4
相关论文
共 50 条
  • [41] The ultra-short virological dynamics in response to entecavir or lamivudine during chronic hepatitis B with spontaneous severe acute exacerbation
    Lee, Teng-Yu
    Chen, Chi-Yi
    Lia, Hsueh-Chou
    Hsu, Yu-Chung
    Yang, Sheng-Shun
    ANTIVIRAL THERAPY, 2018, 23 (01) : 77 - 85
  • [42] Comparable Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir
    Jung Woo Shin
    Joonho Jeong
    Seok Won Jung
    Seung Bum Lee
    Bo Ryung Park
    Min-Ju Kim
    Eun Ji Park
    Neung Hwa Park
    Digestive Diseases and Sciences, 2021, 66 : 1739 - 1750
  • [43] Virologic response maintenance and hepatocellular carcinoma in chronic hepatitis B patients treated with entecavir
    Wang, Xiaomo
    Chen, Yu
    Xu, Manman
    Cheng, Kailiang
    Duan, Xiaoman
    Liao, Wei
    Wang, Yanhong
    Lu, Ying
    Duan, Zhongping
    Wang, Li
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 15 (11) : 1337 - 1344
  • [44] Comparable Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir
    Shin, Jung Woo
    Jeong, Joonho
    Jung, Seok Won
    Lee, Seung Bum
    Park, Bo Ryung
    Kim, Min-Ju
    Park, Eun Ji
    Park, Neung Hwa
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (05) : 1739 - 1750
  • [45] Antiviral treatment in severe acute hepatitis B
    Anca Streinu-Cercel
    Oana Streinu-Cercel
    Alina Cristina Negut
    Marius Stefan
    Adrian Streinu-Cercel
    BMC Infectious Diseases, 14 (Suppl 2)
  • [46] Tenofovir treatment of the severe acute hepatitis B
    Casals-Seoane, Fernando
    Arberas-Diez, Beatriz
    Garcia-Buey, Luisa
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2013, 105 (01) : 57 - 59
  • [47] Lamivudine therapy for severe acute hepatitis B
    Hasan, F
    Owaid, S
    Ali, M
    Asker, H
    Alkhaldi, J
    Varghese, R
    JOURNAL OF HEPATOLOGY, 2005, 42 : 178 - 179
  • [48] Lamivudine in severe acute viral B hepatitis
    Abagiu, AO
    Duna, FM
    Radulescu, CA
    JOURNAL OF HEPATOLOGY, 2003, 38 : 121 - 121
  • [49] Antithrombin as a marker of severe acute hepatitis B
    Simona Arientová
    O. Beran
    P. Chalupa
    M. Kořínková
    M. Holub
    Indian Journal of Gastroenterology, 2019, 38 : 143 - 149
  • [50] RISK FACTORS FOR HEPATOCELLULAR CARCINOMA AMONG PATIENTS WITH CHRONIC HEPATITIS B TREATED WITH ENTECAVIR
    Yamada, R.
    Hiramatsu, N.
    Morishita, N.
    Harada, N.
    Oze, T.
    Yakushijin, T.
    Miyagi, T.
    Yoshida, Y.
    Tatsumi, T.
    Ohkawa, K.
    Kasahara, A.
    Mita, E.
    Hagiwara, H.
    Oshita, M.
    Itoh, T.
    Hijioka, T.
    Yoshihara, H.
    Imai, Y.
    Hayashi, N.
    Takehara, T.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S425 - S425
12345